Ekostatoma - Company finances
|
EUR
|
2022
From: 2022-02-07
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 44,569 | 20,400 | 39,021 | 58,492 |
| Profit before tax | -3,421 | -3,473 | 417 | 12,726 |
| Net profit | -3,421 | -3,473 | 354 | 10,690 |
| Equity | -2,921 | -6,394 | -6,040 | 4,650 |
| Liabilities | 5,044 | 7,517 | 8,143 | 2,149 |
| Non-current assets | 0 | 0 | 528 | 298 |
| Current assets | 2,123 | 1,123 | 1,575 | 6,501 |
| Total assets | 2,123 | 1,123 | 2,103 | 6,799 |
|
Financial indicators
|
||||
| Revenue change y/y | - | -54.2% | +91.3% | +49.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -161.1% | -309.3% | 16.8% | 157.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | 229.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -7.7% | -17.0% | 0.9% | 18.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -7.7% | -17.0% | 1.1% | 21.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | 0.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Ekostatoma - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-06-03 | 2024-06-30 | 64.50 |
| 2024-01-03 | 2024-01-31 | 40.03 |
| 2022-04-01 | 2022-04-30 | 50.95 |
| 2022-03-01 | 2022-03-31 | 40.03 |
Ekostatoma - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Ekostatoma, MB (code 306005256) is a Small partnership active in new construction. In 2025, the company increased revenue to €58.5K, up 49.9% year on year and 186.7% over two years. Profitability also strengthened: net profit rose to €10.7K in 2025 from €354 in 2024, after a loss of €3.5K in 2023. The 2025 profit margin was 18.3%, compared with 0.9% in 2024 and -17.0% in 2023, showing a clear improvement in operating performance. Balance sheet size remained modest, with total assets of €6.8K at the end of 2025, supported by equity of €4.7K and liabilities of €2.1K. Short-term assets accounted for most of the asset base, while long-term assets were €298. The equity ratio was 68.4% and debt-to-equity was 0.46, indicating a relatively conservative capital structure in 2025. Asset turnover reached 8.60x, suggesting that the company generated substantial revenue relative to its asset base.